SCHEMBL7686460

SCHEMBL7686460

CCCCn1cc(CCC2CC2)[nH]c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP2C9 P11712 3/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
DAO P14920 2/20 0.38
CNR2 P34972 4/20 0.37
CNR1 P21554 1/20 0.37
MAPT P10636 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TLR7 Q9NYK1 5/20 0.34
HRH3 Q9Y5N1 1/20 0.34
PDE4A P27815 1/20 0.34
ADORA2A P29274 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685825 0.84 CNR2 (0.40) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7681735 0.83 KMT2A (0.48) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7679685 0.82 KMT2A (0.50) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL14765232 0.79 CYP1A2 (0.54) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7686410 0.79 CYP1A2 (0.54) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7675267 0.77 CYP1A2 (0.44) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7685334 0.77 HTT (0.43) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7677858 0.74 PDE4A (0.40) CYP1A2CYP2C19KMT2AMEN1GAA
SCHEMBL7679806 0.73 CYP2C19 (0.40) CYP1A2CYP2C19KMT2ACYP2C9MEN1
SCHEMBL7682503 0.73 KMT2A (0.44) CYP1A2CYP2C19KMT2ACYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492397-B1 SUCH AS 1-PROPYL-4-BUTYL-1,3-DIHYDRO-3-((5-(2-(1H-TETRAZOL-5-YL)PHENYL)-2 -PYRIDINYL)METHYL)-2H-IMIDAZOL-2-ONE; ANGIO-TENSIN II ANTAGONISTS; CIRCULATORY DISORDERS; HYPERTENSION, CONGESTIVE HEART FAILURE PHARMACIA CORPORATION 2002-12-10 US disclosed
EP-0508393-B1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders SEARLE & CO (US) 1999-06-02 EP disclosed
EP-0579766-B1 N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1999-06-02 EP disclosed
US-5861420-A ANGIOTENSIN II ANTAGONISTS G. D. SEARLE & CO. (US) 1999-01-19 US disclosed
US-5441970-A Administering angiotensin II antagonists to treat congestive heart failure or hypertension G. D. SEARLE & CO. (US) 1995-08-15 US disclosed
EP-0579766-A1 N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-01-26 EP disclosed
WO-1992017469-A2 N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-10-15 WO disclosed
EP-0508393-A1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders G.D. Searle & Co. (US) 1992-10-14 EP disclosed